Connect & Learn
Turning Point hosts a series of webinars presented by experienced clinicians working in the addiction sector.
46 items
- 7 December 2022Since the introduction of MARAM in 2018, the AOD sector has expanded their responsibilities to identify, assess, and respond to family violence risk within operations and service delivery.
- 3 November 2022A recent collaboration between SHARC, Turning Point, and Monash University examined the impact of group-based education and support for affected family members of people experiencing addiction.
- 23 September 2022Tobacco smoking remains one of the largest preventable causes of death and disease in Australia.
- 23 August 2022Using ethnographic research to understand the ways people find of ‘living with’ harmful methamphetamine use
- 5 August 2022Through an exploration of polyvagal theory, the webinar will provide participants with the opportunity to understand the nervous system and how to educate clients about their nervous system and how to regulate when triggered or distressed.
- 22 June 2022Through an exploration of alcohol use in pregnancy, this webinar will provide participants with the opportunity to have an understanding of the extent of the problem.
- 7 June 2022In February 2015, Shanna Whan had her last alcoholic drink after many years of problematic alcohol consumption.
- 13 April 2022The COVID-19 pandemic necessitated the rapid uptake of telehealth services to deliver treatment for alcohol and other drug (AOD) concerns. However, the Telehealth field itself has been expanding since the 1960’s and is far broader than real time video or phone consultations. This webinar explores the range of telehealth services available within behavioural health settings.
- 8 March 2022In our presentation we will provide an overview of the diagnostic criteria for BPD, how to recognise these symptoms as they present in professional settings, the principles of working effectively with people with a diagnosis of BPD, and when and how to make referrals to relevant specialist services (including Spectrum).
- 7 March 2022Long-acting injectable buprenorphine (‘depot buprenorphine’) represents an important new treatment option for the management of opioid dependence.